Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial
HematologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The Lancet. Child & adolescent health
- Publicado em
- 13 abr 2026
- Citações
- 4
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial
Nadja H Vissing, Torjus Skajaa, Dorthe Grosen, Birgitte Klug Albertsen, Bodil Als-Nielsen, Henrik Hasle, Milos M Koch, Annett H Rasmussen, Jesper S Brok, Lisa Hjalgrim et al.
Descritores MeSH
- Anti-Bacterial Agents
- Neoplasms
- Febrile Neutropenia
- Denmark
- Adolescent
- Humans
- Infant
- Male
- Female
- Child
Veja também
Estudos relacionados
- Association of Time to Antibiotics With Outcome in Pediatric Patients Receiving Chemotherapy for Cancer With Fever in Neutropenia-An International Individual Patient Data Meta-Analysis
- A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia
- Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
- Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study)
- Descontinuação precoce vs. continuação de antibióticos empíricos em pacientes com câncer e neutropenia febril: uma revisão sistemática e metanálise de ensaios controlados randomizados